🔎 Trials Near Me

Domov › Rakovina endometria › Wisconsin

Klinické štúdie Rakovina endometria v štáte Wisconsin

24 štúdií pre Rakovina endometria hľadá účastníkov v zariadeniach v štáte Wisconsin.

Mestá v štáte Wisconsin

Oficiálny text štúdie (anglicky)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • ThedaCare Regional Cancer Center, Appleton
  • ThedaCare Regional Medical Center - Appleton, Appleton
  • Duluth Clinic Ashland, Ashland
  • a 42 ďalších
Prebieha náborFáza 2
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05564377

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

  • Medical College of Wisconsin, Milwaukee
Prebieha náborFáza 1
Vek 18 a viac · Ženy · Aktualizované 2. 10. 2026 · NCT05950464

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of Wisconsin Carbone Cancer Center, Madison
Prebieha náborFáza 1/2
Vek 12 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT04585750

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

  • Duluth Clinic Ashland, Ashland
  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay
  • Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay
  • a 8 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Ženy · Aktualizované 2. 10. 2026 · NCT07198074

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

  • Mayo Clinic Health System - Northwest Wisconsin, Eau Claire
  • Mayo Clinic Health System - Southwest Wisconsin, La Crosse
Prebieha náborObservačná štúdia
Vek 18 a viac · Ženy · Aktualizované 29. 9. 2026 · NCT05051722

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

  • Duluth Clinic Ashland, Ashland
  • Northwest Wisconsin Cancer Center, Ashland
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 28. 9. 2026 · NCT05112601

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

  • Research Site, Milwaukee
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06218914

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay
  • Medical College of Wisconsin, Milwaukee
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 24. 9. 2026 · NCT05640999

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

  • Research Site, Madison
Prebieha náborFáza 2
Vek 18 až 130 · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT05489211

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • Froedtert & MCW Cancer Center, Milwaukee
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07109726

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • ThedaCare Regional Cancer Center, Appleton
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT05059444

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

  • Froedtert and Medical College of Wisconsin, Milwaukee
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 21. 8. 2026 · NCT05548296

Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

  • Froedtert Hospital, Milwaukee
Prebieha nábor
Vek 65 a viac · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT07227077

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • University of Wisconsin, Carbone Cancer Center, Madison
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT05919264

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • University of Wisconsin- Madison, Madison
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 8. 2026 · NCT05592626

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  • Research Site, Waukesha
Prebieha náborFáza 3
Vek 18 a viac · Ženy · Aktualizované 29. 7. 2026 · NCT07044336

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

  • 121, Milwaukee
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 16. 7. 2026 · NCT06906341

Study of EV for Recurrent Endometrial Carcinoma

  • Froedtert Memorial Lutheran Hospital, Milwaukee
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 13. 7. 2026 · NCT07139977

Integrated Cancer Repository for Cancer Research

  • Bellin Memorial Hospital, Green Bay
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 19 až 110 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT02012699

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

  • Wisconsin Institute Medical Research- UW Cancer Connect, Madison
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 2. 6. 2026 · NCT06730347

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

  • Froedtert & the Medical College of Wisconsin, Milwaukee
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 11. 2025 · NCT05902988

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Milwaukee
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.